Worldwide Demand For Multiple Sclerosis Drugs Market is Growing at CAGR of 3.9% By 2029

Posted on Aug 4 2022 6:23 AM

"Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection (Intramuscular, Subcutaneous, and Intravenous) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2020-2027"

The global “multiple sclerosis drugs market size” is projected to reach USD 40.66 billion by 2027, exhibiting a CAGR of 7.1% during the forecast period. High prevalence of multiple sclerosis (MS) worldwide will be the primary factor driving the growth of this market, states Fortune Business Insights™ in its report, titled “Multiple Sclerosis Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Immunomodulators, Immunosuppressants, Interferons, and Others), By Route of Administration (Oral and Injection (Intramuscular, Subcutaneous, and Intravenous) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast, 2020-2027”.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/multiple-sclerosis-drugs-market-100386

MS is a widespread degenerative neurological condition among young adults around the world. According to the Multiple Sclerosis Trust, approximately 2.5 million people worldwide are suffering from MS, with a higher number of women getting affected with the condition than men. In the UK, Public Health England, the UK government’s health agency, found that between 2018 and 2020, the number of MS patients rose to 131,720. In the US, on the other hand, data from the National Multiple Sclerosis Society revealed that nearly 1 million people in the US are living with MS. Increasing incidence of this condition, therefore, is expected to surge the MS drugs market growth.

List of Key Players Covered in the Multiple Sclerosis Drugs Market Report:

  • Bristol-Myers Squibb Company (New York, U.S.)
  • Sanofi (Paris, France)
  • Novartis AG (Basel, Switzerland)
  • Pfizer Inc. (New York, U.S.)
  • Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel)
  • Merck & Co., Inc. (New Jersey, U.S.)
  • Hoffmann-La Roche Ltd. (Basel, Switzerland)
  • Biogen (Massachusetts, U.S.)

Regional Insights

Healthy Awareness about MS to Feed Market Growth in North America

North America boasted a market size of USD 14.74 billion in 2019 on account of widespread awareness about MS and its treatments. In the US, government bodies such as the Multiple Sclerosis Association of America conducts educational drives during the month of March, which is recognized as the Multiple Sclerosis Awareness Month in the country.

Europe is expected to hold a prominent position in the multiple sclerosis drugs market size, share during the forecast period owing to supportive health reimbursement policies. In Asia Pacific, the market is anticipated to perform remarkably well as pharmaceutical companies are aggressively expanding their distribution networks across the region.

Regional Analysis:

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Multiple Sclerosis Drugs Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/multiple-sclerosis-drugs-market-100386

Primary Research:

Various sources from both the supply and demand sides were interviewed during the primary research process to obtain qualitative and quantitative information for this report. Primary sources included industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations from all segments of the value chain of this industry. To obtain and verify critical qualitative and quantitative information, in-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants

Detailed Table of Content:

  • Global Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Drug Class
      • Immunomodulators
      • Immunosuppressants
      • Interferons
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
        • Intramuscular
        • Subcutaneous
        • Intravenous
      • Market Analysis, Insights and Forecast – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
      • Market Analysis, Insights and Forecast – By Region
        • North America
        • Europe
        • Asia Pacific
        • Latin America
        • Middle East & Africa
      • North America Multiple Sclerosis Drugs Market Analysis, Insights and Forecast, 2018-2029
        • Market Analysis, Insights and Forecast – By Drug Class
          • Immunomodulators
          • Immunosuppressants
          • Interferons
          • Others
        • Market Analysis, Insights and Forecast – By Route of Administration
          • Oral
          • Injection
            • Intramuscular
            • Subcutaneous
            • Intravenous

Continued…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Pune - 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs